Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

743
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

781
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
781
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

616
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
616
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

671
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One Versus Two 3-Minute Cryoballoon Ablations Per Pulmonary Vein for Paroxysmal Atrial Fibrillation: The One Freeze Trial.

Heart rhythm·2026
Same author

Peak QRS/T ratio and the spatial ventricular gradient differentiate acute vs chronic left bundle branch block after transcatheter aortic valve replacement.

Heart rhythm O2·2026
Same author

Electrophysiological observations during and after transcatheter aortic valve replacement.

Heart rhythm·2026
Same author

HRS position statement: Changing the tide in CPR and AED education for students in the United States.

Heart rhythm·2026
Same author

Establishing a national cardiopulmonary resuscitation program in Indian high schools and colleges: An expert collaborative call to action and implementation model.

Heart rhythm·2026
Same author

Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement.

JAMA cardiology·2025

Related Experiment Video

Updated: Mar 24, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

28.9K

Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study.

Gabriel C Brooks1, Byron K Lee1, Rajni Rao1

  • 1Department of Medicine, Division of Cardiology, University of California San Francisco, San Francisco, California.

Journal of the American College of Cardiology
|March 12, 2016
PubMed
Summary
This summary is machine-generated.

Persistent severe left ventricular (LV) systolic dysfunction after myocardial infarction (MI) can improve. A predictive model using clinical variables at MI presentation helps identify patients likely to recover LV function.

Keywords:
heart failureremodelingrisk assessmentventricular ejection fraction

More Related Videos

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.7K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.8K

Related Experiment Videos

Last Updated: Mar 24, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

28.9K
Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

3.7K
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.8K

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Medical Research

Background:

  • Persistent severe left ventricular (LV) systolic dysfunction post-myocardial infarction (MI) significantly increases mortality risk.
  • Such dysfunction is a primary indication for cardioverter-defibrillator implantation.

Purpose of the Study:

  • To develop predictive models for LV recovery after acute MI.
  • To identify independent predictors of LV ejection fraction (EF) recovery to >35% and ≥50% at 90-day follow-up.

Main Methods:

  • A multicenter prospective observational study enrolled 231 patients with initial EF ≤35% post-MI.
  • Multivariate modeling identified predictors of EF recovery, which were validated in a separate cohort of 236 patients.

Main Results:

  • 57% of patients with severe LV dysfunction (EF ≤35%) achieved EF recovery to >35% within 90 days.
  • Predictive models incorporating baseline EF, prior MI, peak troponin, and other clinical factors accurately estimated recovery probabilities, ranging from 9% to 87% for EF >35% and 4% to 49% for EF ≥50%.

Conclusions:

  • A significant proportion of patients with severe LV dysfunction post-MI experience functional recovery.
  • Clinical variables available at the time of MI can effectively predict the likelihood of LV recovery.